-
-
-
-
-
-
-
Inspire Medical (INSP), ResMed (RMD) on Watch Following Report on Sleep Apnea
-
-
-
-
-
-
-
YS Biopharma (YS) Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
-
-
-
-
-
-
-
Macrogenics (MGNX) Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
-
-
-
-
-
-
-
Moderna (MRNA) Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
-
-
-
-
-
-
-
Madrigal Pharma (MDGL) Confirms FDA Approval of Rezdiffra for Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
-
-
-
-
-
-
-
Acadia Pharma (ACAD) Reports Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin
-
-
-
-
-
-
-
Regenxbio (RGNX) Climbs 30% Following New Positive Initial Efficacy Data From Affinity Duchenne Trial
-
5,507 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Hot FDA News reports.